Skip to main content
OpenTrials
Completed

NCT Number: NCT03399617

SPOON: Sustained Program for Improving Nutrition - Guatemala

The primary goal of this study is to assess the impact of an innovative strategy to prevent undernutrition and obesity in early childhood in children 0-24 months in Guatemala. This study is designed to evaluate the impact of promoting adequate infant an young child feeding practices and the use of SQ-LNS (Small Quantity Lipid-Based Nutrient Supplements) on the nutritional status of infants and young children. The study will be conducted in Baja Verapaz, Guatemala in conjunction with Fundazucar, Guatemala.

Completed

Looking for future studies?

Notify Me

Key information

About this study

SPOON Guatemala is an innovative strategy to prevent undernutrition and obesity in children aged 0-24 months living in high-poverty areas of Guatemala. SPOON focuses on improving feeding practices for infant and young children, including exclusive breastfeeding, and promote the use of home-fortification with peanut-based SQ-LNS (small quantity lipid-based nutrient supplements) through a novel behavior change strategy.

The study will recruit children between 0 and 3 months of age as well as pregnant women in the third trimester. Mothers or caregivers of eligible children will be invited to participate and a consent form obtain. Participation will start at 0-6 months and the intervention will last until children are 24 months. Participants will be randomly assigned at the community level to one of two groups: a control group and a treatment group. Participants in the control group will receive the standard services provided by their local health clinics in addition to a supply of micronutrient powders from 6-24 months of age, according to the national protocol. Participants in the treatment group will be randomly assigned at an individual level to receive two different interventions:

Treatment 1: This group will receive SQ-LNS supplement from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

Treatment 2. This group will receive micronutrient powders from 6-24 months and an innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

A sample size of 500 children per group has been calculate to detect a minimum effect size of 0.2 with 95% level of significance and a 80% power for use of SQ-LNS. Additionally, a sample size of 40 communities and 500 children per group has been calculated to detect a minimum detectable effect size of 0.32 for communication.

Main outcomes include infant and young child feeding practices, height, weight, hemoglobin, prevalence of anemia, prevalence of stunting, prevalence of obesity, and weight gain rate. A baseline and final survey will be conducted to collect data for these variables, as well as sociodemographic information. Impact estimation will be done comparing the average results and the distribution of indicators between the treatment and control group. Differences of simple means and regression models including co-variables of the child's age and sex, and characteristics of the primary caregiver and household will be estimated. In addition to potential changes in indicator averages, changes in the distribution of variables will be explored under the hypothesis that the intervention might not only improve average value for a given indicator, but compress the distribution over a range of values closer to an optimal range. Changes to distributions will be checked by applying the Kolmogorov-Smirnov test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women in the third trimester or children 3 months of age
  • Living in the defined intervention areas
  • Children with no chronic diseases or congenital malformations
  • Not planning on moving far from the intervention area in the next 24 months

Exclusion criteria

  • Children with any chronic disease or congenital malformation
  • Caretakers of the children plan on moving in the next 24 months
  • Children with severe acute malnutrition

Treatment and study plan

Micronutrient Powders

Dietary Supplement

Micronutrient powders (5 nutrient formulation) are currently provided by the Guatemalan Ministry of Health to children between 6-24 months of age.

Other names: MNPs

SPOON behavioral change strategy

Behavioral

An innovative behavioral change strategy designed using ethnographic and marketing methods to promote adequate infant and young child feeding practices and the use of SQ-LNS. The strategy will be delivered to mothers or caregivers through individual home-visits, group sessions, and community mobilization activities.

SQ-LNS

Dietary Supplement

SQ-LNS is a peanut-based ready to use home fortification product to improve diet quality in children 6-24 months of age. It includes peanuts and other ingredients such as vegetable fat, powdered milk and several micronutrients. The formulation designed for this study does not include sugar.

Other names: Smal Quantity Lipid-base Nutrient Supplements

Primary outcomes

  1. Infant and young child feeding practices

    Time frame: Measured at baseline and after 24 months of intervention

    Set of indicators of infant and young child feeding practices obtained by interview to participant mothers or caregivers

  2. Height

    Time frame: Measured at 6 and 24 months of age

    Height-for-age z score obtained by measuring the height of participant children

  3. Weight gain rate

    Time frame: Constructed from weight measurements at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 months of age

    Rate of weight gain from 0-24 months of age

  4. Hemoglobin

    Time frame: Measured at 6 and 24 months of age

    Measurement of hemoglobin using a portable photometer

  5. Prevalence of obesity in children

    Time frame: Measured at 6 and 24 months of age

    Population estimation of obesity using Population estimation of obesity using Body Mass Index (BMI)

  6. Prevalence of stunting

    Time frame: Measured at 6 and 24 months of age

    Population estimation of stunting using height-for age <-2 SD

  7. Prevalence of anemia

    Time frame: Measured at 6 and 24 months of age

    Population estimation of anemia using hemoglobin

Secondary outcomes

  1. Adherence to Nutritional Supplement Regime

    Time frame: Measured every months from 6 months of age until the end of the intervention

    Consumption of the nutritional supplement measured as the number of packets consumed in one month

  2. Exclusive Breastfeeding

    Time frame: Measured 24 months after the start of the intervention

    Measured as an indicator of exclusive breastfeeding, self-reported by the mother of a child

Sponsors and collaborators

Lead sponsor

Inter-American Development Bank

Other

Collaborators

  • Fundazúcar
  • The PepsiCo Foundation

Registry information

Official study title

Effect of an Innovative Behavioral Change Strategy and SQ-LNS on Stunting and Obesity in Children Living in Baja Verapaz, Guatemala

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Jan 16, 2018
Registry last updated
Mar 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.